Sebastian Ochoa Gonzalez, MD
- Allergy and Immunology
Assistant Professor, Pediatrics - Allergy & Immunology, Baylor College of Medicine
Phone:
832-824-1319
Languages: English
Office location:
Texas Medical Center
6701 Fannin Street
Houston, TX 77030
Get to know Sebastian Ochoa Gonzalez, MD
Personal Statement
My goals are to deliver comprehensive and compassionate clinical care to patients with immunodeficiency, mentor the upcoming generation of allergists-immunologists, and help advance the field through my research in inborn errors of immunity and immunogenetics.
Clinical Interests
Inborn errors of immunity, human genetics
Education
| School | Education | Degree | Year |
|---|---|---|---|
| NIH/NIAID | Fellowship | Allergy & Immunology | 2023 |
| MedStar Health - Georgetown University Hospital | Residency | Internal Medicine | 2018 |
| CES University School of Medicine, Medellin, Colombia | Medical School | Doctor of Medicine | 2012 |
Organizations
| Organization Name | Role |
|---|---|
| American Academy of Allergy, Asthma, and Immunology | Member |
| Asthma and Allergy Proceedings | Executive Editorial Board Member |
| Clinical Immunology Society (CIS) | Member |
Honors and awards
- 2022
-
Award for Innovation in Teaching, National Institutes of Health, National Institute of Allergy, and Infectious Diseases Fellowship Program
- 2016
-
W. Proctor Harvey MD Memorial Intern of the Year Award, Medstar Georgetown University Hospital, Department of Medicine
- 2015
-
CHEST Young Investigator Award, American College of Chest Physicians
- 2012
-
Alfonso Velez Correa Top Medical School Graduate Award, CES University School of Medicine, Medellin, Colombia
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Research interests
Inborn errors of immunity, immune dysregulation, immunogenetics
Ochoa S, Abers MS, Rosen LB, et al. Management and outcome of COVID-19 in CTLA-4 insufficiency. Blood Advances. 2023;7(19):5743-5751.
Khoury P, Srinivasan R, Kakumanu S, Ochoa S, et al. A Framework for Augmented Intelligence in Allergy and Immunology Practice and Research—A Work Group Report of the American Academy of Allergy, Asthma & Immunology Health Informatics, Technology, and Education Committee. The Journal of Allergy and Clinical Immunology: In Practice. 2022;10(5):1178-1188.
Ferré EMN*, Schmitt MM*, Ochoa S*, et al. SARS-CoV-2 spike protein-directed monoclonal antibodies may ameliorate COVID-19 complications in APECED patients. Frontiers in Immunology. 2021;12:720205. *equal contribution
Bastard P, Orlova E, Sozaeva L, and Levy R, James A, Schmitt MM, Ochoa S, et al. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. Journal of Experimental Medicine. 2021;218(7):e20210554.
Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515). DOI: 10.1126/science.abd4585.
Ochoa S, Ding L, Kreuzburg S, Treat J, Holland SM, Zerbe CS. Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-gamma Autoantibodies. Clinical Infectious Diseases. 2021;72(12):2206-2208.
View Google Scholar Publications